Fig. 1From: Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathwaySynthesis of rosiglitazone metformin adduct (RZM). a–d The infrared spectroscopy analysis results of Ros, Met, the mixture of Ros and Met, and RZMBack to article page